Research with clinical data,from outside the hospital

Backed by

• Analyze now, without the paperwork

  This data was given directly by patients who hoped it would help research. Only de-identified results leave, so you can analyze without waiting on review.

  In type 2 diabetes, what share stopped a GLP-1 because of GI side effects?

  Here is the share who stopped because of GI side effects.

  Nausea · vomiting11%

  Diarrhea6%

  Abdominal pain4%

  Answer (illustrative)

• Cite the data in your paper

  Once you have IRB approval, validate your hypothesis statistically on real-world data and cite that data in your paper.

Frequently asked questions

Is IRB review not required?

The exploratory stage runs without review. Results are de-identified and counts for very small groups are not shown, so it does not constitute research using identifiable information. Once you settle on a hypothesis and move to the study itself, IRB approval is required.

Can results be used for publications or regulatory submissions as is?

Not as is. Once you have IRB approval, you can review the de-identified source records behind a finding and use them either as a citation in your paper or as supporting material in a regulatory filing. We help you prepare for that review.

Is patient personal information visible?

No. Every identifier is removed before analysis, counts for very small groups are not shown, and only the minimum clinically meaningful information is used.